Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PPAR gamma Inhibitors

Santa Cruz Biotechnology now offers a broad range of PPAR gamma Inhibitors for use in various applications. PPAR gamma Inhibitors are crucial in the study of peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor that plays a significant role in the regulation of lipid metabolism and glucose homeostasis. These inhibitors are instrumental for researchers delving into the molecular mechanisms that underlie energy balance and metabolic function in cells. By modulating PPARγ activity, scientists can explore its impact on gene expression related to lipid uptake and adipogenesis, thereby gaining insights into the complex network of metabolic regulation. The study of PPAR gamma Inhibitors allows for a deeper understanding of transcription factors in cellular differentiation, particularly in adipocytes. This research is pivotal in explaining how specific genetic expressions influence metabolic pathways and can help in identifying key regulatory nodes within metabolic networks. Their use extends to the field of nutrigenomics, where understanding how nutrients affect gene expression through pathways like those controlled by PPARγ is vital. By offering these inhibitors, Santa Cruz Biotechnology supports cutting-edge research aimed at deciphering the fundamental processes that govern cellular metabolism and energy regulation. View detailed information on our available PPAR gamma Inhibitors by clicking on the product name.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Saroglitazar

495399-09-2sc-473154
2.5 mg
$430.00
(0)

A dual PPARα/γ agonist, uniquely influencing lipid and glucose metabolism. By activating PPARα, it boosts lipid catabolism, effectively reducing triglycerides. Concurrently, its PPARγ activation enhances insulin sensitivity, aiding in glycemic regulation. This dual mechanism allows for a targeted modulation of metabolic pathways, making saroglitazar a compound of interest in metabolic research, particularly in understanding the interplay between lipid and glucose homeostasis.

Teneligliptin

760937-92-6 (free base)sc-475074
25 mg
$260.00
1
(0)

While primarily a DPP-4 inhibitor, teneligliptin has also shown some PPARy modulating effects, contributing to its anti-diabetic action.